Clinical Trials
5 trialsNCT04692103 2026-01-22
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
University of Washington
Phase 2 Active not recruiting
NCT06260033 2025-10-06
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer
City of Hope Medical Center
Phase 2 Recruiting
NCT02409316 2025-08-08
[18F]FES PET/CT in Endocrine Refractory Breast Cancer
University of Pennsylvania
Phase 2 Completed
NCT03703492 2025-02-12
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS
University of Wisconsin, Madison
Phase 2 Completed
NCT03065712 2020-05-12
Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET
University of Texas Southwestern Medical Center
Phase 2 Withdrawn